Pharma Journalist -

Novavax, Inc. a biotechnology company developing next-generation vaccines for serious infectious diseases, announced that it has reached an agreement with the European Commission (EC)…
Read More...

EQRx, a company committed to developing and delivering important new medicines at radically lower prices, and AbCellera, a technology company with a centralized operating system for…
Read More...

Eli Lilly and Company and Incyte announced results from an additional cohort of 101 adult patients from the COV-BARRIER trial. In this sub-study, patients with COVID-19 on mechanical…
Read More...

As part of Sanofi’s endeavor to accelerate the application of messenger RNA (mRNA) to develop therapeutics and vaccines, the company has entered into a definitive agreement with…
Read More...

Burning Rock Biotech Limited announced a global strategic partnership with IMPACT Therapeutics in companion diagnostics (CDx) development for a pipeline of drugs in the field of…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq…
Read More...

DisperSol Technologies, a clinical-stage pharmaceutical company developing new treatments for oncology and rare diseases, and Catalent, the leading global provider of advanced delivery…
Read More...

Alkermes plc announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to nemvaleukin alfa (nemvaleukin), the company's novel, investigational…
Read More...

Ipsen and Exicure Inc. have signed an exclusive collaboration agreement to research, develop, and commercialize novel Spherical Nucleic Acids (SNAs) as potential investigational…
Read More...

SMi Reports: Uncover the evolving research into smart vaccines for COVID-19 and accelerating accessibility of new wearable technologies The global wearable biosensors market is a…
Read More...